James W. Green - 01 Jan 2022 Form 4 Insider Report for HARVARD BIOSCIENCE INC (HBIO)

Role: Chief Executive Officer, Director
Signature: /s/ David Sirois, by power of attorney
Issuer symbol: HBIO
Transactions as of: 01 Jan 2022
Net transactions value: -$334,339
Form type: 4
Filing time: 03 Jan 2022, 18:48:03 UTC
Previous filing: 30 Dec 2021
Next filing: 03 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HBIO	Common Stock	Tax liability	$334,339	-47,424	-2.3%	$7.05	1,977,554	01 Jan 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock unit award previously granted to the Reporting Person which vested in part on January 1, 2022.
F2	Includes (a) 218,141 remaining restricted stock units that will vest on June 11, 2022 and 2023, (b) 129,799 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (c) 109,070 remaining restricted stock units that will vest on December 29, 2022 and 2023, (d) 104,590 remaining restricted stock units that will vest on January 1, 2023, (e) 605,035 restricted stock units with performance based vesting conditions tied to relative total shareholder return, and (f) 810,919 shares of common stock beneficially owned by the Reporting Person.

Content

The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock unit award previously granted to the Reporting Person which vested in part on January 1, 2022.

Includes (a) 218,141 remaining restricted stock units that will vest on June 11, 2022 and 2023, (b) 129,799 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (c) 109,070 remaining restricted stock units that will vest on December 29, 2022 and 2023, (d) 104,590 remaining restricted stock units that will vest on January 1, 2023, (e) 605,035 restricted stock units with performance based vesting conditions tied to relative total shareholder return, and (f) 810,919 shares of common stock beneficially owned by the Reporting Person.